These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1749353)

  • 1. [Psychopathological heterogeneity in opium drug addicts].
    Pani PP; Carta M; Rudas N
    Minerva Psichiatr; 1991; 32(3):145-50. PubMed ID: 1749353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood disorders in opioid-dependent patients.
    Ahmadi J; Majdi B; Mahdavi S; Mohagheghzadeh M
    J Affect Disord; 2004 Oct; 82(1):139-42. PubMed ID: 15465588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
    Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK
    Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevalence of psychiatric co-morbidity among opioid addicts].
    Frei A; Rehm J
    Psychiatr Prax; 2002 Jul; 29(5):258-62. PubMed ID: 12101492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention.
    Kokkevi A; Stefanis N; Anastasopoulou E; Kostogianni C
    Addict Behav; 1998; 23(6):841-53. PubMed ID: 9801720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathology in opioid addicts.
    Kosten TR; Rounsaville BJ
    Psychiatr Clin North Am; 1986 Sep; 9(3):515-32. PubMed ID: 3774603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric morbidity among adults in The Netherlands: the NEMESIS-Study. II. Prevalence of psychiatric disorders. Netherlands Mental Health Survey and Incidence Study].
    Bijl RV; van Zessen G; Ravelli A
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2453-60. PubMed ID: 9555131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood disorders affect drug treatment success of drug-dependent pregnant women.
    Fitzsimons HE; Tuten M; Vaidya V; Jones HE
    J Subst Abuse Treat; 2007 Jan; 32(1):19-25. PubMed ID: 17175395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
    Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
    J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.
    Feinstein A; Stergiopoulos V; Fine J; Lang AE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):169-76. PubMed ID: 11513100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mental disorders and the course of opiate dependence].
    Verthein U; Degkwitz P; Krausz M
    Psychiatr Prax; 2000 Mar; 27(2):77-85. PubMed ID: 10738738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse in hospitalized psychiatric patients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mental disorders of drug addicts in treatment: a study of prevalence with retrospective evaluation by means of structured diagnostic interviews].
    Pozzi G; Tacchini G; Di Giannantonio M; Tempesta E
    Minerva Psichiatr; 1995 Sep; 36(3):139-54. PubMed ID: 8583883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychiatric comorbidity in risk groups of opioid addiction: a comparison between opioid dependent and non-opioid dependent prisoners (in jail due to the German narcotics law)].
    Franke P; Neef D; Weiffenbach O; Gänsicke M; Hautzinger M; Maier W
    Fortschr Neurol Psychiatr; 2003 Jan; 71(1):37-44. PubMed ID: 12529833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year incidence of psychiatric disorders and associated risk factors among adolescents in the community.
    Roberts RE; Roberts CR; Chan W
    J Child Psychol Psychiatry; 2009 Apr; 50(4):405-15. PubMed ID: 19175820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.